WallStreetZenWallStreetZen

NASDAQ: SGMT
Sagimet Biosciences Inc Stock Forecast, Predictions & Price Target

Analyst price target for SGMT

Based on 3 analysts offering 12 month price targets for Sagimet Biosciences Inc.
Min Forecast
$26.00+470.18%
Avg Forecast
$33.00+623.68%
Max Forecast
$46.00+908.77%

Should I buy or sell SGMT stock?

Based on 3 analysts offering ratings for Sagimet Biosciences Inc.
Strong Buy
Strong Buy
1 analysts 33.33%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SGMT stock forecasts and price targets.

SGMT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-26
lockedlocked$00.00+00.00%2024-03-25
lockedlocked$00.00+00.00%2024-02-07

1 of 1

SGMT revenue forecast

What is SGMT's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$72.2M+3,509.25%
Avg 2 year Forecast
$236.0M+11,698.5%
Avg 3 year Forecast
$487.5M+24,274.25%

SGMT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SGMT$4.56$33.00+623.68%Strong Buy
GLYC$2.26$10.00+343.46%Buy
CLLS$2.61$6.00+129.89%Buy
RPTX$3.47$17.50+404.32%Strong Buy
CRVO$23.35$65.00+178.37%Strong Buy

Sagimet Biosciences Stock Forecast FAQ

Is Sagimet Biosciences Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: SGMT) stock is to Strong Buy SGMT stock.

Out of 3 analysts, 1 (33.33%) are recommending SGMT as a Strong Buy, 2 (66.67%) are recommending SGMT as a Buy, 0 (0%) are recommending SGMT as a Hold, 0 (0%) are recommending SGMT as a Sell, and 0 (0%) are recommending SGMT as a Strong Sell.

If you're new to stock investing, here's how to buy Sagimet Biosciences stock.

What is SGMT's revenue growth forecast for 2028-2030?

(NASDAQ: SGMT) Sagimet Biosciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Sagimet Biosciences's revenue in 2024 is $2,000,000.On average, 2 Wall Street analysts forecast SGMT's revenue for 2028 to be $2,303,703,933, with the lowest SGMT revenue forecast at $1,559,631,658, and the highest SGMT revenue forecast at $3,047,776,209. On average, 2 Wall Street analysts forecast SGMT's revenue for 2029 to be $7,530,719,915, with the lowest SGMT revenue forecast at $3,747,966,889, and the highest SGMT revenue forecast at $11,313,472,942.

In 2030, SGMT is forecast to generate $15,557,541,204 in revenue, with the lowest revenue forecast at $9,675,333,122 and the highest revenue forecast at $21,439,749,287.

What is SGMT's Price Target?

According to 3 Wall Street analysts that have issued a 1 year SGMT price target, the average SGMT price target is $33.00, with the highest SGMT stock price forecast at $46.00 and the lowest SGMT stock price forecast at $26.00.

On average, Wall Street analysts predict that Sagimet Biosciences's share price could reach $33.00 by Mar 26, 2025. The average Sagimet Biosciences stock price prediction forecasts a potential upside of 623.68% from the current SGMT share price of $4.56.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.